Clinical Trial Update: A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion [Phase 1]

View source ↗

Summary

This document reports a Phase Ib study of JMKX000197 injection for malignant pleural effusion that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion

Drugs mentioned

• JMKX000197

Snippet

Sponsor: Jemincare | Conditions: Malignant Pleural Effusions (Mpe) | Phase 1 | Status: RECRUITING